Olmeben 40 mg (Tablet)

Unit Price: ৳ 15.00 (3 x 10: ৳ 450.00)
Strip Price: ৳ 150.00

Medicine Details

Category Details
Generic Olmesartan medoxomil
Company Navana pharmaceuticals ltd
Also available as
Olmeben 20 mg tablet

Title

  • Olmeben 40 mg Tablet

Categories

  • Hypertension Treatment
  • Antihypertensive Medication

Description

  • Olmeben is indicated for the treatment of hypertension
  • May be used alone or in combination with other antihypertensive agents
  • Blocks the vasoconstrictor effects of angiotensin II
  • Dosage must be individualized
  • No initial dosage adjustment is recommended for elderly patients
  • Usual recommended starting dose is 20 mg once daily
  • No significant drug interactions with digoxin or warfarin
  • Not metabolized by the cytochrome P450 system
  • Contraindicated in patients hypersensitive to any component
  • Well tolerated, with an incidence of adverse reactions similar to placebo
  • Reversible renal function changes may be anticipated
  • No experience of overdose with Olmeben
  • Store in cool & dry place below 30°C, protect from light & moisture
  • Molecular Formula: C29H30N6O6
  • Therapeutic Class: Angiotensin-ll receptor blocker

Dimensions

    Color Options

      Functions

      • Treatment of hypertension
      • Vasoconstrictor effects blocking
      • Individualized dosage
      • Reversible renal function changes anticipation

      Materials

        Technical Specifications

        • Dosage: 20 mg once daily as starting dose
        • No significant drug interactions reported
        • Non-metabolized by cytochrome P450 system
        • Molecular Formula: C29H30N6O6

        Design Elements

          Usability Features

          • May be used alone or in combination with other antihypertensive agents
          • No initial dosage adjustment for elderly patients

          Indications

          • Treatment of hypertension

          Pharmacology

          • Angiotensin II is formed from angiotensin I in a reaction catalyzed by ACE
          • Principal pressor agent of the renin-angiotensin system
          • Blocks the vasoconstrictor effects of angiotensin II by selectively blocking the AT 1 receptor

          Mode of Action

          • Blocks the vasoconstrictor effects of angiotensin II by selectively blocking the AT 1 receptor

          Dosage & Administration

          • Usual recommended starting dose: 20 mg once daily
          • No initial dosage adjustment recommended for elderly patients

          Interaction

          • No significant drug interactions with digoxin or warfarin
          • Not metabolized by the cytochrome P450 system

          Contraindications

          • Hypersensitivity to any component of this product

          Side Effects

          • Adverse reactions similar to placebo
          • No differences in adverse reactions based on gender, age, and race
          • Rate of withdrawals due to adverse reactions was low
          • Incidence of cough was similar in placebo and Olmeben patients

          Pregnancy & Lactation

          • Discontinue product during pregnancy
          • Potential adverse effects on nursing infants

          Precautions & Warnings

          • Changes in renal function may be anticipated in susceptible individuals

          Overdose Effects

          • Hypotension and tachycardia may occur in overdose

          Commonly Asked Questions

          • Uses: Treatment of high blood pressure
          • Frequency: Generally used once or twice a day
          • Storage Instructions

          Therapeutic Class

          • Angiotensin-ll receptor blocker

          Storage Conditions

          • Cool & dry place below 30°C, protect from light & moisture

          Chemical Structure

          • Molecular Formula: C29H30N6O6

          Precautions

          • Inhibiting the renin-angiotensin-aldosterone system may lead to changes in renal function

          Related Brands